331 related articles for article (PubMed ID: 15660022)
21. Inhibition of inflammatory corneal angiogenesis by TNP-470.
Joussen AM; Beecken WD; Moromizato Y; Schwartz A; Kirchhof B; Poulaki V
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2510-6. PubMed ID: 11581191
[TBL] [Abstract][Full Text] [Related]
22. Analysis of angiogenesis induced by cultured corneal and oral mucosal epithelial cell sheets in vitro.
Kanayama S; Nishida K; Yamato M; Hayashi R; Sugiyama H; Soma T; Maeda N; Okano T; Tano Y
Exp Eye Res; 2007 Dec; 85(6):772-81. PubMed ID: 17904552
[TBL] [Abstract][Full Text] [Related]
23. Endogenous TNFalpha suppression of neovascularization in corneal stroma in mice.
Fujita S; Saika S; Kao WW; Fujita K; Miyamoto T; Ikeda K; Nakajima Y; Ohnishi Y
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3051-5. PubMed ID: 17591872
[TBL] [Abstract][Full Text] [Related]
24. The novel tubulin-binding drug BTO-956 inhibits R3230AC mammary carcinoma growth and angiogenesis in Fischer 344 rats.
Shan S; Lockhart AC; Saito WY; Knapp AM; Laderoute KR; Dewhirst MW
Clin Cancer Res; 2001 Aug; 7(8):2590-6. PubMed ID: 11489843
[TBL] [Abstract][Full Text] [Related]
25. Laminin binding to the calreticulin fragment vasostatin regulates endothelial cell function.
Yao L; Pike SE; Tosato G
J Leukoc Biol; 2002 Jan; 71(1):47-53. PubMed ID: 11781379
[TBL] [Abstract][Full Text] [Related]
26. Anti-angiogenic activities of hypericin in vivo: potential for ophthalmologic applications.
Lavie G; Mandel M; Hazan S; Barliya T; Blank M; Grunbaum A; Meruelo D; Solomon A
Angiogenesis; 2005; 8(1):35-42. PubMed ID: 16132616
[TBL] [Abstract][Full Text] [Related]
27. Corneal endothelial modulation: bFGF as direct mediator and corneal endothelium modulation factor as inducer.
Kay EP; Gu X; Smith RE
Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2427-35. PubMed ID: 8163333
[TBL] [Abstract][Full Text] [Related]
28. PEDF-derived peptide inhibits corneal angiogenesis by suppressing VEGF expression.
Matsui T; Nishino Y; Maeda S; Yamagishi S
Microvasc Res; 2012 Jul; 84(1):105-8. PubMed ID: 22386653
[TBL] [Abstract][Full Text] [Related]
29. Thrombospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide.
BenEzra D; Griffin BW; Maftzir G; Aharonov O
Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3601-8. PubMed ID: 8258518
[TBL] [Abstract][Full Text] [Related]
30. [Inhibitory effects of ampelopsin on angiogenesis].
Luo GQ; Zeng S; Liu DY
Zhong Yao Cai; 2006 Feb; 29(2):146-50. PubMed ID: 16617784
[TBL] [Abstract][Full Text] [Related]
31. The inhibitory effects of recombinant plasminogen kringle 1-3 on the neovascularization of rabbit cornea induced by angiogenin, bFGF, and VEGF.
Kim JH; Kim JC; Shin SH; Chang SI; Lee HS; Chung SI
Exp Mol Med; 1999 Dec; 31(4):203-9. PubMed ID: 10630375
[TBL] [Abstract][Full Text] [Related]
32. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
33. [Suppression of corneal neovascularization by conditioned culture medium of human amniotic membrane].
Ma X; Bazan H; Li J
Zhonghua Yan Ke Za Zhi; 2003 Dec; 39(12):753-6. PubMed ID: 14769230
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of ocular angiogenesis by diced small interfering RNAs (siRNAs) specific to vascular endothelial growth factor (VEGF).
Murata M; Takanami T; Shimizu S; Kubota Y; Horiuchi S; Habano W; Ma JX; Sato S
Curr Eye Res; 2006 Feb; 31(2):171-80. PubMed ID: 16500768
[TBL] [Abstract][Full Text] [Related]
35. Topical Ranibizumab inhibits inflammatory corneal hem- and lymphangiogenesis.
Bucher F; Parthasarathy A; Bergua A; Onderka J; Regenfuss B; Cursiefen C; Bock F
Acta Ophthalmol; 2014 Mar; 92(2):143-8. PubMed ID: 22994268
[TBL] [Abstract][Full Text] [Related]
36. Acidic/neutral amino acid residues substitution in NH2 terminal of plasminogen kringle 5 exerts enhanced effects on corneal neovascularization.
Li C; Li L; Cheng R; Dai Z; Li C; Yao Y; Zhou T; Yang Z; Gao G; Yang X
Cornea; 2013 May; 32(5):680-8. PubMed ID: 23343948
[TBL] [Abstract][Full Text] [Related]
37. The effect of topical infliximab on corneal neovascularization in rabbits.
Kim JW; Chung SK
Cornea; 2013 Feb; 32(2):185-90. PubMed ID: 23146933
[TBL] [Abstract][Full Text] [Related]
38. Wound healing angiogenesis: indirect stimulation by basic fibroblast growth factor.
Knighton DR; Phillips GD; Fiegel VD
J Trauma; 1990 Dec; 30(12 Suppl):S134-44. PubMed ID: 1701493
[TBL] [Abstract][Full Text] [Related]
39. Anti-angiogenic activity of inositol hexaphosphate (IP6).
Vucenik I; Passaniti A; Vitolo MI; Tantivejkul K; Eggleton P; Shamsuddin AM
Carcinogenesis; 2004 Nov; 25(11):2115-23. PubMed ID: 15297368
[TBL] [Abstract][Full Text] [Related]
40. Suppression of choroidal neovascularization by intramuscular polymer-based gene delivery of vasostatin.
Sheu SJ; Chou LC; Bee YS; Chen JF; Lin HC; Lin PR; Lam HC; Tai MH
Exp Eye Res; 2005 Dec; 81(6):673-9. PubMed ID: 15967435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
